Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda

NCT00674921 is registered in ClinicalTrials.gov with MRC/UVRI and LSHTM Uganda Research Unit as lead sponsor.

NCT NCT00674921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00674921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Lead sponsor
MRC/UVRI and LSHTM Uganda Research Unit
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2008
Completion date
June 30, 2011
Enrollment
1,650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections